Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TFAP2A | hg38_v1_chr6_-_10419638_10419665 | 0.35 | 5.1e-02 | Click! |
ZNF711 | hg38_v1_chrX_+_85244075_85244121 | -0.02 | 9.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_+_46098102 Show fit | 11.28 |
ENST00000300527.9
ENST00000310645.9 |
collagen type VI alpha 2 chain |
|
chr19_-_45322867 Show fit | 8.92 |
ENST00000221476.4
|
creatine kinase, M-type |
|
chr2_+_176122712 Show fit | 6.65 |
ENST00000249499.8
|
homeobox D9 |
|
chr10_-_44385043 Show fit | 5.95 |
ENST00000374426.6
ENST00000395794.2 ENST00000374429.6 ENST00000395793.7 ENST00000343575.10 ENST00000395795.5 |
C-X-C motif chemokine ligand 12 |
|
chr17_+_4584519 Show fit | 5.94 |
ENST00000389313.9
|
smoothelin like 2 |
|
chr10_-_123891742 Show fit | 5.85 |
ENST00000241305.4
ENST00000615851.4 |
carboxypeptidase X, M14 family member 2 |
|
chr19_-_55147319 Show fit | 5.80 |
ENST00000593046.5
|
troponin T1, slow skeletal type |
|
chr1_-_201429857 Show fit | 5.78 |
ENST00000336092.8
|
troponin I1, slow skeletal type |
|
chr11_-_66317037 Show fit | 5.77 |
ENST00000311330.4
|
CD248 molecule |
|
chr11_-_6320494 Show fit | 5.68 |
ENST00000303927.4
ENST00000530979.1 |
caveolae associated protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 55.9 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.2 | 34.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
1.2 | 33.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.6 | 28.7 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 24.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
1.3 | 22.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 21.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.8 | 20.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 20.8 | GO:0006415 | translational termination(GO:0006415) |
2.3 | 20.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 226.2 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 180.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 104.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 71.5 | GO:0016604 | nuclear body(GO:0016604) |
0.4 | 65.2 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 53.7 | GO:0005925 | focal adhesion(GO:0005925) |
2.2 | 46.6 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 44.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 41.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 34.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 438.2 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 130.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.4 | 58.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.4 | 50.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 34.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
2.3 | 32.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 31.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.3 | 27.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.8 | 26.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 24.3 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 110.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.9 | 67.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 52.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 37.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 32.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 26.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.7 | 26.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 25.1 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.3 | 24.8 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 24.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 76.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 72.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.6 | 66.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 35.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 33.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.9 | 25.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 22.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 21.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 20.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 20.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |